StreetAlpha
REGENXBIO Inc. · SEC Form 4

RGNX Insider Trading

From SEC Form 49 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of REGENXBIO Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are net buyers over the last 12 months: $949K bought and $940K sold.

← RGNX stock page

Insiders are net buyers
Bought, 12 months$949K1 buys · 1 insiders
Sold, 12 months$940K4 sales · 1 insiders
Net+$9Kbought minus sold
Planned sales27%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFeb2026-03: sold $53KMarApr2026-05: sold $169KMayJun2026-07: sold $718KJul2026-08: bought $949KAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when RGNX insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an RGNX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every RGNX insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Aug 27, 2026Gregory Austin CiongoliDirectorBuy102,603$9.25$949K118,035Aug 27Form 4
Jul 2, 2026Steve PakolaChief Medical OfficerSale plan2,161$13.64$29K213,009Jul 6Form 4
Jul 1, 2026Steve PakolaChief Medical OfficerSale56,333$12.23$689K213,009Jul 1Form 4
May 11, 2026Steve PakolaChief Medical OfficerSale plan15,309$11.02$169K232,617May 13Form 4
Mar 10, 2026Steve PakolaChief Medical OfficerSale plan5,124$10.35$53K247,926Mar 12Form 4
Oct 9, 2025Curran SimpsonCEOSale plan20,811$12.62$263K216,162Oct 10Form 4
Sep 29, 2025Curran SimpsonCEOSale plan7,624$10.03$76K236,973Oct 1Form 4
Sep 10, 2025Curran SimpsonCEOSale plan7,734$10.02$77K244,597Sep 12Form 4
May 12, 2025Kenneth T. MillsDirectorSale plan20,602$7.91$163K475,103May 14Form 4

RGNX insider trading FAQ

Are RGNX insiders buying or selling?

Insiders are net buyers over the last 12 months. 1 insiders bought $949K of RGNX on the open market in 1 trades, and 1 sold $940K in 4 trades, 27% of that under pre-arranged trading plans.

When did an RGNX insider last buy shares?

Gregory Austin Ciongoli (Director) bought 102,603 shares for $949K on Aug 27, 2026, reported on Aug 27, 2026.

When did an RGNX insider last sell shares?

Steve Pakola (Chief Medical Officer) sold 2,161 shares for $29K on Jul 2, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice